Stock DNA
Pharmaceuticals & Biotechnology
INR 789 Cr ()
30.00
37
0.00%
0.00
0.00%
3.62
Total Returns (Price + Dividend) 
Anlon Healthcare for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
08-Aug-2026 | Source : BSEAnlon Healthcare Limited has informed the exchange about the Share Swap Agreement ("SSA").
Board Meeting Intimation for Approve Notice Of 13Th Annual General Meeting Of The Company
06-Aug-2026 | Source : BSEAnlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the transaction mentioned in Prior Intimation of Board Meeting.
Closure of Trading Window
06-Aug-2026 | Source : BSEWe have attached herewith intimation as per Reg. 30 of SEBI (LODR) Regulation 2015.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
Anlon Healthcare Ltd has announced 2:10 stock split, ex-date: 24 Apr 26
Anlon Healthcare Ltd has announced 1:1 bonus issue, ex-date: 24 Apr 26
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 6 FIIs (1.67%)
Punitkumar R Rasadia (34.98%)
Shree Dwarikadhish Ventures Llp (7.53%)
26.19%
Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is -44.10% vs 55.76% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is -50.97% vs 90.10% in Mar 2026
Annual Results Snapshot (Standalone) - Mar'26
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period